Literature DB >> 12067445

Clinical protocol. A phase II study: efficacy of the gene therapy of the MVA E2 recombinant virus in the treatment of precancerous lesions (NIC I and NIC II) associated with infection of oncogenic human papillomavirus.

Carlos Manual Corona Gutierrez1, Alberto Tinoco, Mario López Contreras, Tania Navarro, Patricia Calzado, Laura Vargas, Lise Reyes, Roberto Posternak, Ricardo Rosales.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12067445     DOI： 10.1089/104303402753812520

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN： 1043-0342            Impact factor:   5.695


× No keyword cloud information.
  6 in total

Review 1.  [Prophylactic and therapeutic vaccines against human papilloma virus].

Authors:  A E Albers; T K Hoffmann; J P Klussmann; A M Kaufmann
Journal:  HNO       Date:  2010-08       Impact factor: 1.284

2.  Local HPV Recombinant Vaccinia Boost Following Priming with an HPV DNA Vaccine Enhances Local HPV-Specific CD8+ T-cell-Mediated Tumor Control in the Genital Tract.

Authors:  Yun-Yan Sun; Shiwen Peng; Liping Han; Jin Qiu; Liwen Song; Yachea Tsai; Benjamin Yang; Richard B S Roden; Cornelia L Trimble; Chien-Fu Hung; T-C Wu
Journal:  Clin Cancer Res       Date:  2015-09-29       Impact factor: 12.531

3.  Regression of human papillomavirus intraepithelial lesions is induced by MVA E2 therapeutic vaccine.

Authors:  Ricardo Rosales; Mario López-Contreras; Carlos Rosales; Jose-Roberto Magallanes-Molina; Roberto Gonzalez-Vergara; Jose Martin Arroyo-Cazarez; Antonio Ricardez-Arenas; Armando Del Follo-Valencia; Santiago Padilla-Arriaga; Miriam Veronica Guerrero; Miguel Angel Pirez; Claudia Arellano-Fiore; Freddy Villarreal
Journal:  Hum Gene Ther       Date:  2014-12       Impact factor: 5.695

Review 4.  Modified vaccinia virus Ankara as antigen delivery system: how can we best use its potential?

Authors:  Ingo Drexler; Caroline Staib; Gerd Sutter
Journal:  Curr Opin Biotechnol       Date:  2004-12       Impact factor: 9.740

Review 5.  Medical treatment of cervical intraepithelial neoplasia II, III: an update review.

Authors:  Chumnan Kietpeerakool; Jatupol Srisomboon
Journal:  Int J Clin Oncol       Date:  2009-02-20       Impact factor: 3.850

6.  In vitro host range, multiplication and virion forms of recombinant viruses obtained from co-infection in vitro with a vaccinia-vectored influenza vaccine and a naturally occurring cowpox virus isolate.

Authors:  Malachy Ifeanyi Okeke; Øivind Nilssen; Ugo Moens; Morten Tryland; Terje Traavik
Journal:  Virol J       Date:  2009-05-12       Impact factor: 4.099
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.